 |
 |
|
|
|
| L-arginine hydrochloride |
 |
| L-arginine hydrochloride |
 |
| 1119-34-2 |
 |
L-arginine hydrochloride
CAS No. :1119-34-2
Molecular formula: C6H14N4O2
Molecular Weight: 174.20
Appearance: white crystal or crystalline powder, special acidity, soluble in water and formic acid, slightly soluble in ethanol.
Assay: 99.0 ~ 101.0%
Production standards: AJI92, USP26
Rotation: +22.1 ~ +22.9
Heavy metals ¡Â 10ppm
Moisture content ¡Â 0.20%
Residue on ignition ¡Â 0.10%
PH 4.7 ~ 6.2
Use: L-arginine hydrochloride, the active ingredient is L-arginine, used in medicine to help wound healing, stimulate the development of the immune system, enhance the secretion of hormones, promote urinary circulation, reduce blood ammonia levels, treatment of ammonia poisoning. Acute viral hepatitis, chronic persistent hepatitis and cirrhosis have a better therapeutic effect, and the prevention and treatment of fatty liver, play an effective hepatoprotective effect.
Packing: 25kg/drum
Mail:ycgc_int04 at ycgccreate com
|
 |
L-arginine hydrochloride
CAS No. :1119-34-2
Molecular formula: C6H14N4O2
Molecular Weight: 174.20
Appearance: white crystal or crystalline powder, special acidity, soluble in water and formic acid, slightly soluble in ethanol.
Assay: 99.0 ~ 101.0%
Production standards: AJI92, USP26
Rotation: +22.1 ~ +22.9
Heavy metals ¡Â 10ppm
Moisture content ¡Â 0.20%
Residue on ignition ¡Â 0.10%
PH 4.7 ~ 6.2
Use: L-arginine hydrochloride, the active ingredient is L-arginine, used in medicine to help wound healing, stimulate the development of the immune system, enhance the secretion of hormones, promote urinary circulation, reduce blood ammonia levels, treatment of ammonia poisoning. Acute viral hepatitis, chronic persistent hepatitis and cirrhosis have a better therapeutic effect, and the prevention and treatment of fatty liver, play an effective hepatoprotective effect.
Packing: 25kg/drum
Mail:ycgc_int04 at ycgccreate com
|
|
|
|
 |
|
|
|
|
|
 |
| There are no existing companies to distribute selected chemical product |
|
 |
|
|
|
